$Evoke Pharma, Inc.(EVOK)$ 8-K - Current report Filed: 2017-11-14 AccNo: 0001564590-17-023783 Size: 318 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Evoke Pharma, Inc.(EVOK)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-14 AccNo: 0001564590-17-023771 Size: 3 MB 网页链接
$Evoke Pharma, Inc.(EVOK)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-14 AccNo: 0001564590-17-023771 Size: 3 MB 网页链接
$Evoke Pharma, Inc.(EVOK)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2017-11-14 AccNo: 0001193125-17-342602 Size: 711 KB 网页链接
$Evoke Pharma, Inc.(EVOK)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2017-11-14 AccNo: 0001193125-17-342602 Size: 711 KB 网页链接
$Evoke Pharma, Inc.(EVOK)$ 8-K - Current report Filed: 2017-11-09 AccNo: 0001564590-17-023007 Size: 33 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接
$Evoke Pharma, Inc.(EVOK)$ 美东时间 2017-11-14 盘后 披露财报,预期EPS -0.17 网页链接
$Evoke Pharma, Inc.(EVOK)$ 8-K - Current report Filed: 2017-10-23 AccNo: 0001564590-17-019709 Size: 35 KBItem 8.01: Other Events 网页链接
$Evoke Pharma, Inc.(EVOK)$ CT ORDER - Confidential treatment order Filed: 2017-09-22 AccNo: 9999999997-17-008818 Size: 10 KB 网页链接
$Evoke Pharma, Inc.(EVOK)$ 8-K - Current report Filed: 2017-09-12 AccNo: 0001564590-17-018568 Size: 34 KBItem 8.01: Other Events 网页链接